Gilead Sciences, Inc. vs UnitedHealth Group Incorporated — Stock Comparison
Q·Score Breakdown
8.1
Buy
Overall
6.3
Hold
Quality
Health
Growth
Valuation
Sentiment
GILD
High-quality business with 41% return on equity and 29% profit margins.
UNH
82% of 28 covering analysts rate it Buy or Strong Buy.
⚠ limited growth momentum.
Analyst Consensus
BUY
Target $158.36 (+20.1%)
28 analysts
BUY
Target $387.27 (+5.1%)
26 analysts
Fundamentals
GILD
UNH
19.5×
Trailing P/E
27.8×
13.7×
Forward P/E
17.7×
28.9%
Profit Margin
2.7%
78.8%
Gross Margin
18.8%
40.7%
ROE
12.2%
4.7%
Revenue Growth
2.0%
23.4%
Earnings Growth
0.7%
0.40
Beta
0.41
—
Price / Book
—
$163.7B
Market Cap
$334.6B
$95 – $157
52-Week Range
$235 – $412
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.